Brokerage 8 Jun. 2020

Quimdis pharmaceuticals division presents: PELLETS PHARMA LIMITED

Manufacturing of preformulation intermediate for pellets

Activities

• Contract manufacturing of pellets
• Regulatory approvals: E GMP
• New technology: Nano and Powderlayer

Products

• Omeprazole 8.5%
• Tamsulosin HCl SR
• Esomeprazole EC
• Venlafaxine SR
• Aprepitant IR
• Dimethyl fumarate mini tablet
• Dabigatran IR